BioCentury | Jun 10, 2013
Company News

BIOCND Inc., Genor Biopharma deal

...Genor granted BIOCND development rights to two mAbs. Genor granted BIOCND rights to GB232 , an...
...international IND application at the end of the year for a Phase I trial of GB232...
Items per page:
1 - 1 of 1